Obstetric thromboprophylaxis.
Thromboembolism in pregnancy is a major cause of maternal mortality. Pregnancy, particularly caesarean section, increases the risk of thrombosis. This article discusses the risk factors, the drugs used and the indications for prophylaxis of thromboembolism in pregnancy.
Nelson-Piercy
C
C
Institute of Obstetrics and Gynaecology, Queen Charlotte's Hospital, London.
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002585:Cesarean Section / Q000009:adverse effects; D018890:Chemoprevention; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007744:Obstetric Labor Complications / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control*; D011295:Prenatal Care; D012008:Recurrence; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D006493:Heparin; D001241:Aspirin